The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Study of the dosimetry, safety, and potential benefit of 177Lu-PSMA-617 radionuclide therapy prior to radical prostatectomy in men with high-risk localized prostate cancer (LuTectomy study).
 
Omar Alghazo
No Relationships to Disclose
 
Renu Eapen
No Relationships to Disclose
 
Nattakorn Dhiantravan
No Relationships to Disclose
 
John A. Violet
No Relationships to Disclose
 
Price Jackson
No Relationships to Disclose
 
Mark Scalzo
No Relationships to Disclose
 
Simon P. Keam
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
 
Catherine Mitchell
No Relationships to Disclose
 
Paul J. Neeson
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Allergan; Bristol-Myers Squibb; Compugen; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedImmune; Roche/Genentech
 
Shahneen Kaur Sandhu
Honoraria - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merck Serono (Inst)
Consulting or Advisory Role - Amgen
Speakers' Bureau - Bristol-Myers Squibb; Merck; Roche/Genentech
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Endocyte/Advanced Accelerator Applications (Inst); Genentech/Roche (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Scott Williams
Consulting or Advisory Role - Amgen; Janssen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
 
Daniel Moon
No Relationships to Disclose
 
Nathan Lawrentschuk
No Relationships to Disclose
 
Arun Azad
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; Merck Serono; Novartis; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Novartis
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma; Astellas Pharma (Inst); AstraZeneca; AstraZeneca (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); MedImmune (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Synthorx (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Janssen; Merck Serono; Sanofi
 
Michael S Hofman
Consulting or Advisory Role - Endocyte; Janssen
Research Funding - Endocyte (Inst)
Travel, Accommodations, Expenses - Genzyme; Ipsen; Janssen
 
Declan G. Murphy
Honoraria - Astellas Pharma; AstraZeneca; Ferring; Ipsen; Janssen Oncology
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; Janssen Oncology
Travel, Accommodations, Expenses - Device Technologies